Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03482973 · ClinicalTrials.gov registry record · Phase 3
Pecto-Intercostal Fascial Block for Postoperative Analgesia After Cardiac Surgery
A Phase 3 study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 80
- Enrollment target
NCT03482973: Completed Phase 3 study, sponsored by Beth Israel Deaconess Medical Center.
NCT03482973 is a Phase 3 study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 80 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03482973, a Phase 3 study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether administration of a pecto-intercostal fascial plane block (PIFB) with bupivacaine is a more effective therapy for postoperative analgesia after cardiac surgery as compared to patients who receive a sham block of normal saline.
Primary Outcome
Total opioid consumption in the first 48 hours post-operatively, measured as milligram morphine equivalents (MME).
Interventions
- OTHER Placebo
- DRUG Bupivacaine Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2018-06-21 |
| Est. Completion | 2019-11-27 |
| Phase | Phase 3 |
What the finished NCT03482973 record still lists
NCT03482973 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03482973 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03482973 about?
NCT03482973 is a clinical study titled "Pecto-Intercostal Fascial Block for Postoperative Analgesia After Cardiac Surgery". The purpose of this study is to determine whether administration of a pecto-intercostal fascial plane block (PIFB) with bupivacaine is a more effective therapy for postoperative analgesia after cardiac surgery as compared to patients who receive a sham block of normal saline.
What is the current status of trial NCT03482973?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 80 participants. The study started on 2018-06-21. Estimated completion is 2019-11-27.
What interventions are being tested in trial NCT03482973?
The interventions under investigation include: Placebo (OTHER), Bupivacaine Group (DRUG).
Who is sponsoring clinical trial NCT03482973?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03482973's enrollment target sits among peer trials
80 1755th of 2000 higher than 233 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI